Key result
Higher BPV in hypertensives is linked to CV events, microvascular damage, and ~97% higher diabetes risk.
Why the study?
Hypertensive microvascular disorder leads to substantial target organ damage, and blood pressure variability has been identified as an independent risk factor exacerbating endothelial injury.
Blood pressure variability acts as an independent pathogenic mechanism for hypertensive microvascular complications, suggesting that maintaining BPV stability is crucial for early prevention and treatment.
The hypertensive microvascular disorder is a significant complication that can lead to substantial target organ damages, including cognitive impairments, visual impairments, and deterioration in renal function. Recent studies have indicated that blood pressure variability (BPV) is an independent risk factor for the progression of this pathology. The present paper aims to systematically elucidate the concept, classification, and clinical significance of BPV, focusing on how it acts as a pathogenic mechanism independent of mean blood pressure to exacerbate endothelial injury and cause target organ damage. This review was conducted to evaluate the influences of multiple factors on BPV, including neurohumoral regulation, the behavioural environment and comorbidities. It also emphasises the intrinsic link between BPV and microvascular complication risk in specific populations, such as those with diabetes and obesity. In summary, it is evident that a comprehensive exploration of the underlying mechanisms of BPV is imperative for the early prevention and treatment of hypertensive microvascular diseases.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2026) conducted a review in Adults with hypertension at risk for microvascular complications including elderly and those with diabetes and obesity. Blood pressure variability is an independent risk factor exacerbating microvascular damage and cardiovascular events in hypertensive adults, with reported hazard ratios up to 1.97 for diabetes risk and odds ratio 1.171 for retinopathy risk.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: